Medical Aesthetics now offers Advanced Regenerative Medicine Therapy called AmnioFix technology, which is an innovative, all-natural injection therapy designed to rapidly treat patients with soft tissue complications. AmnioFix is an amazing alternative for patients who are not interested in surgery, and have not found relief through more conservative options such as NSAID and Therapy. AmnioFix is composed of growth factors, which are powerful agents that are capable of stimulating cellular migration, cellular growth, cellular duplication and cellular differentiation. The growth factors contained in AmnioFix signal local cells to help heal and grow the damaged tissue. Simply put, AmnioFix is a “stem cell” magnet!
AmnioFix is a human amniotic membrane allograft. There have been more than 1,000,000 allografts distributed for soft tissue applications in eye surgery, dental surgery, orthopedic surgery, pain management, and wound care. Other forms of amniotic membrane have been used for almost 100 years. AmnioFix is amniotic membrane supplied in a powder form so surgeons may deliver the benefits of the tissue through an injection.
Soft tissue injuries are often caused by trauma, age, or overuse of the affected area. Micro-tears in the tissue form and become inflamed and the scar tissue may form and impede a full recovery. Conservative treatments options usually help heal the area, but if additional treatment is necessary, you may consider AmnioFix injection therapy. AmnioFix contains naturally occurring regulatory proteins that reduce inflammation and scar tissue formation, while increasing healing in soft tissue injuries, as well as, providing prolonged pain relief in osteoarthritis. The AmnioFix injection is performed in the office as an outpatient procedure.
Amniotic tissue has been used to treat injuries since the early 1900's and is considered very safe. Amniotic membrane has been the subject of many scientific and clinical publications evaluating its use in:
All of the amniotic membrane tissue for AmnioFix is donated by healthy consenting mothers undergoing scheduled Caesarean section. Amniotic membrane is a sac surrounding the baby and is typically discarded after the baby is born. The recovery of the membrane does not affect the baby or the delivery process and therefore the donation process does not share the ethical concerns associated with embryonic tissue. All tissue donors are tested for infectious diseases, similar to the testing done for blood donation. The amniotic membrane then undergoes a validated patented process to thoroughly clean and preserve the tissue, called the PURION Process.